|
RNPEP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.57119999999655E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65108999999886E-05 |
| Normal-vs-Stage2 |
3.863800E-02 |
| Normal-vs-Stage3 |
5.916300E-03 |
| Normal-vs-Stage4 |
1.166170E-02 |
| Stage1-vs-Stage2 |
5.360600E-01 |
| Stage1-vs-Stage3 |
1.659990E-01 |
| Stage1-vs-Stage4 |
3.647600E-01 |
| Stage2-vs-Stage3 |
7.634000E-01 |
| Stage2-vs-Stage4 |
9.118000E-01 |
| Stage3-vs-Stage4 |
8.062800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.33600000000878E-05 |
| Normal-vs-AfricanAmerican |
5.421100E-03 |
| Normal-vs-Asian |
1.059470E-03 |
| Caucasian-vs-AfricanAmerican |
6.231200E-01 |
| Caucasian-vs-Asian |
1.379410E-01 |
| AfricanAmerican-vs-Asian |
2.348600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.299500E-03 |
| Normal-vs-Female |
1.25079999691025E-08 |
| Male-vs-Female |
8.02760000000458E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.627800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.189260E-04 |
| Normal-vs-Age(61-80Yrs) |
1.569920E-04 |
| Normal-vs-Age(81-100Yrs) |
2.850600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.306600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.772000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.364800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.843200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.956800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.243400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.156500E-04 |
| Normal-vs-Grade 2 |
2.3789999999968E-05 |
| Normal-vs-Grade 3 |
4.997100E-04 |
| Normal-vs-Grade 4 |
3.723100E-03 |
| Grade 1-vs-Grade 2 |
2.594400E-01 |
| Grade 1-vs-Grade 3 |
1.810960E-01 |
| Grade 1-vs-Grade 4 |
2.217000E-01 |
| Grade 2-vs-Grade 3 |
4.742600E-01 |
| Grade 2-vs-Grade 4 |
7.516600E-01 |
| Grade 3-vs-Grade 4 |
8.397600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.03929999553765E-08 |
| Normal-vs-ccB subtype |
5.993700E-02 |
| ccA subtype-vs-ccB subtype |
7.381000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.646580E-04 |
| Normal-vs-N1 |
7.788400E-04 |
| N0-vs-N1 |
2.518600E-01 |
|
|
